It’s a major step back from comments made at a White House news conference in September.
By MATTHEW PERRONE, AP Health Writer
WASHINGTON (AP) The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back statements by President D… [+4759 chars]
